A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Center for International Blood and Marrow Transplant Research
Takeda
Eli Lilly and Company
Eli Lilly and Company
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Ossium Health, Inc.
Orca Biosystems, Inc.
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
Eli Lilly and Company
Medical College of Wisconsin
University of Michigan Rogel Cancer Center
Eli Lilly and Company
Novartis
Massachusetts General Hospital
Constellation Pharmaceuticals
Dana-Farber Cancer Institute
Azienda USL Reggio Emilia - IRCCS
Fred Hutchinson Cancer Center
Cogent Biosciences, Inc.
Celgene
Novartis
Eli Lilly and Company
Shenzhen University General Hospital
Ruijin Hospital
Augusta University
Celularity Incorporated
University of Leipzig
Zhejiang University
Anhui Provincial Hospital
Xuzhou Medical University
Vincerx Pharma, Inc.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
AO GENERIUM
Medical University of Vienna
Masonic Cancer Center, University of Minnesota
Amgen
Baptist Health South Florida
Takeda
Baylor College of Medicine
Rigshospitalet, Denmark
Takeda
Stanford University
University of Illinois at Chicago
Pfizer
Novartis
Phoenix Children's Hospital